Effect of eplerenone versus spironolactone on cortisol levels and the proportion of glycosylated haemoglobin in patients with chronic heart failure.

Trial Profile

Effect of eplerenone versus spironolactone on cortisol levels and the proportion of glycosylated haemoglobin in patients with chronic heart failure.

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Mar 2011

At a glance

  • Drugs Eplerenone (Primary) ; Spironolactone (Primary)
  • Indications Chronic heart failure
  • Focus Pharmacodynamics
  • Most Recent Events

    • 10 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top